US retailers that move early to tailor product ranges and merchandise their shelves targeting GLP-1 users may be better positioned to protect share as eating behaviors change. GlobalData projects that the GLP-1 pill market will grow from $3.2 billion in 2025 to $34.3 billion in 2031, with an annual CAGR of 48.4% over the six-year period
Individual factors like starting weight, diet, exercise, and metabolism affect how quickly you see changes
Research material is supplied as a lyophilized (freeze-dried) powder that must be reconstituted with bacteriostatic water before it can be measured and drawn
The pattern suggests that each additional receptor target provides incremental but meaningful improvements
The key to success is preparation, realistic expectations, and flexibility
Association of bile duct and gallbladder diseases with the use of incretin-based drugs in patients with type 2 diabetes mellitus